Patients with HIV who are resistant to all four antiretroviral drug classes face a higher risk for death than those who are ...

The global HIV antivirals market is set for a period of robust growth, with a new forecast predicting its value will climb ...

The S&P/ASX 200 is set for a relatively quiet start on Monday, despite major US benchmarks surging to record levels.